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The cytosolic yeast Hsp40 Ydj1 contains a conserved
zinc finger-like region (ZFLR), which has two zinc-bind-
ing domains (ZBD), that helps regulate and specify
Hsp70 function. To investigate the mechanism for Ydj1
ZFLR action, ZBDI and ZBDII mutants were constructed
and characterized. ZBDII mutants exhibited tempera-
ture-sensitive growth defects, but yeast tolerated muta-
tion of ZBDI. However, ZBDI and ZBDII mutants were
defective at facilitating androgen receptor (AR) folding.
Defective AR folding was associated with the accumula-
tion of complexes between AR and Ydj1 ZFLR mutants
and a reduction in Hsp70AR complex formation. Puri-
fied Ydj1 ZBDI and ZBDII mutants could bind non-na-
tive polypeptides but could not deliver luciferase to
Hsp70 and were defective at luciferase refolding. Inter-
estingly, the ability of Ydj1 to synergize with Hsp70 to
suppress thermally induced protein aggregation was
blocked by mutation of ZBDII, but not ZBDI. Hence,
ZBDII is required for yeast to survive heat stress be-
cause it is essential for Ydj1 to cooperate with Hsp70 to
suppress protein aggregation. On the other hand, pro-
tein folding is dependent upon the action of both ZBDI
and ZBDII because each is required for Hsp70 to capture
non-native polypeptides from Ydj1.
Members of the heat shock protein (Hsp)1 70 family function
with different Hsp40 co-chaperones to facilitate essential as-
pects of protein metabolism that include ribosome assembly,
protein translocation, protein folding, suppression of polypep-
tide aggregation, -amyloid fibril assembly, and cell signaling
(1–3). The yeast Type I Hsp40 Ydj1 and Type II Hsp40 Sis1
cooperate with cytosolic heat shock protein 70 Ssa1 to facilitate
different aspects of cellular protein metabolism (4–8). Study of
Ydj1 and Sis1 action serves as a model system to investigate
mechanisms for specification of eukaryotic Hsp70 function by
Hsp40 co-chaperones (4–8).
Current models for the Hsp70 polypeptide binding and re-
lease cycle indicate that Hsp40s interact with non-native
polypeptides prior to Hsp70 to prevent their aggregation (9–
11). Hsp40-bound substrates are subsequently transferred to
Hsp70 in a process that involves Hsp40-dependent hydrolysis
of ATP by Hsp70 (3). The mechanism by which Hsp40s function
to bind and transfer non-native polypeptides to Hsp70 has been
the subject of several studies, but is not well defined (12, 13).
Answers to questions pertaining to the mechanism by which
Hsp40s bind and deliver substrates to Hsp70 are complicated
by the fact that the Hsp40 family is large and structurally
diverse (2). The Hsp40 family can be divided into three differ-
ent subtypes. All Hsp40s contain a 75-amino acid J domain,
which contains the family signature HPD motif that interacts
with the ATPase domain of Hsp70 to stimulate ATP hydrolysis
(14). Ydj1 is a Type I Hsp40 that is related to Escherichia coli
DnaJ and human Hdj2. Type I Hsp40s appear to function as
homodimers and contain an amino-terminal J domain that is
located adjacent to a glycine and phenylalanine-rich region
that is followed by a zinc finger-like region (ZFLR) and con-
served carboxyl-terminal domains I and II (CTDI and CTDII).
Type II Hsp40s, such as human Hdj1 and yeast Sis1, contain
all of the aforementioned subdomains except that ZFLR has
been replaced by a glycine and methionine-rich region. Type III
Hsp40s contain a J domain and other specialized domains that
enable them to interact with highly specific substrates. Hsp70
family members are often co-localized in subcellular compart-
ments with several different members of the Hsp40 family.
Thus, multiple Hsp40s can interact with a single Hsp70 to
generate specialized Hsp70Hsp40 pairs that facilitate specific
reactions in cellular protein metabolism.
Ydj1 and Sis1 bind non-native polypeptides and utilize this
capability in the yeast cytosol to specify reactions catalyzed by
Hsp70 (4–8). However, Ydj1 and Sis1 are not functionally
equivalent (4, 5) and exhibit major differences in chaperone
function (6). In vivo studies have demonstrated that overex-
pression of Sis1 complements the slow growth phenotype of
ydj1, but Ydj1 cannot complement the lethal phenotype of a
sis1 (4, 5). Purified Ydj1 can function independently of Hsp70
to suppress protein aggregation (11), whereas Sis1 requires the
assistance of Hsp70 to perform this function (6). In addition,
the Ydj1Hsp70 chaperone pair refolds denatured luciferase
with several-fold greater efficiency than Sis1Hsp70 (6). When
the centrally located polypeptide-binding domains of Ydj1 and
Sis1 are swapped to form YSY and SYS, these chimeric Hsp40s
exhibit in vivo complementation activity, substrate specificity,
and protein folding activity identical to that of Sis1 and Ydj1,
respectively (8). In related studies the glycine and phenylala-
nine regions of Ydj1 and Sis1, which are not identical, were also
demonstrated to influence the functional specificity of these
Hsp40s (7). Thus, regions within the central portion of Ydj1
and Sis1 play a critical role in specifying the cellular functions
of Hsp70 (7, 8).
The centrally located chaperone module of Ydj1 is conserved
in all type I Hsp40s and is constructed from residues 102–255
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(8). Ydj1 (102–255) contains the ZFLR and an additional
-sandwich domain that is capable of binding peptide sub-
strates (15). The Ydj1 ZFLR lies adjacent to the -sandwich
domain, is constructed from residues 143–209, and contains 4
repeated Cys-X-X-Cys-X-Gly-X-Gly motifs that function in
pairs to form zinc-binding domains (ZBD) I and II. The NMR
structure of a 79-residue ZFLR fragment from E. coli DnaJ
depicts this domain to have a novel fold with an overall V-
shaped extended -hairpin topology, which is conserved in Ydj1
(15, 16). The calculated surface of the Type I Hsp40 ZFLR has
a number of sites that have the potential to be involved in
protein-protein interactions, but it does not contain an obvious
patch of hydrophobic residues that is often found in the
polypeptide binding sites of molecular chaperones (16). None-
theless, mutations in the ZFLR reduce the chaperone activity of
Type I Hsp40s, (17, 18), and amino acid residues within the
Hsp40 ZFLR can be cross-linked to model protein substrates
(19). These collective data suggest that the ZFLR is required for
Type I Hsp40s to cooperate with Hsp70 to facilitate protein
folding, but its mode of operation remains obscure.
To investigate the role that the Type I Hsp40 ZFLR plays in
the regulation of Hsp70 function we characterized the func-
tional defects exhibited by a set of Ydj1 ZFLR point mutants in
which either ZBDI or ZBDII was mutated. Results from in vivo
complementation studies demonstrated that ZDBII is essential
for cells to survive heat stress and is essential for viability in
the absence of full-length Sis1. Mutation of the Ydj1 ZFLR led
to defects in androgen receptor function that correlated with
the accumulation of Ydj1AR complexes and a corresponding
decrease in Hsp70AR complexes. Purified Ydj1 ZFLR mutants
were also found to be defective in refolding chemically dena-
tured luciferase, and this defect was pinpointed to a step in the
Hsp40/Hsp70 polypeptide binding and release cycle where
Ydj1-bound substrates are transferred to Hsp70. These collec-
tive data demonstrated that Type I Hsp40 ZFLR is required for
Hsp70 to capture non-native polypeptide from Ydj1.
EXPERIMENTAL PROCEDURES
Yeast Strains and Plasmids—The following yeast strains were uti-
lized in this study: MYY405U (ydj1), MATa, leu2, his3, ydj1::ura3
(20); JJ1146 (ydj1sis1), MATa trp1–1 ura3–1 leu2–3, 112 his3–11, 15
ade2–1 can1–100 met2-1 lys2-2 ydj1::HIS3 sis1::LEU2/pYCp50-
Sis1/pRS314-Sis1-(1–121) (21); CYY501, JJ1146/MATa trp1–1 ura3–1
leu2–3, 112 his3–11, 15 ade2–1 can1–100 met2-1 lys2-2 ydj1::HIS3
sis1::LEU2)/pRS315-SIS1. Two-step PCR was performed to prepare
Ydj1 C143S, Ydj1 C162S, Ydj1 C185S, and Ydj1 C201S. YDJ1 and the
YDJ1 ZFLR mutants were subcloned into pRS412 and pRS315 (22) and
pET11a (23, 24). pG1-hAR (human androgen receptor) was described
previously (25).
Cell Viability Assays—ydj1 was transformed with pRS315 that
harbored YDJ1 or the indicated YDJ1 ZFLR mutant. Transformants
were selected and cultured under selection in synthetic dextrose me-
dium for 2 days at 25 °C. Cells (0.2 A600 nm) were then serially diluted
(1:10), and 5 l of each dilution was spotted onto a yeast extract,
peptone, and dextrose (YPD) plate. YPD plates were photographed after
3 days of incubation at the indicated temperature.
sis1ydj1 that harbored pYCP50-SIS1 and pRS314-SIS1 (1–121)
was transformed with pRS412 that harbored YDJ1 or the indicated
YDJ1 ZFLR mutant. Transformations were then cultured under selec-
tion for 2 days at 25 °C in synthetic dextrose. Then, to drive the loss of
pYCP50-SIS1 from cells and make growth dependent upon the chaper-
one function of Ydj1, aliquots (12 l) of cultures were spotted on syn-
thetic dextrose plates that were supplemented with 5-FOA (26). After 7
days of incubation at 25 °C, plates were photographed.
Assay for Androgen Receptor Activity—Activity of human androgen
receptor, which was exogenously expressed under the control of the
GAL promoter in ydj1 that expressed Ydj1 or the indicated Ydj1 ZFLR
mutant, was assayed as previously described (25). Briefly, cells were
grown in selective synthetic medium containing 2% galactose instead of
glucose to an A600 nm of 0.2. Aliquots (1 ml) of cultures were then
supplemented with the synthetic androgen 3H-R1881 (50 nM; DuPont)
and then incubated for 1.5 h. Cells were pelleted and washed three
times with 1 ml of water. The quantity of 3H-R1881 specifically retained
in cells that expressed the androgen receptor was then determined by
scintillation counting. Nonspecific retention of 3H-R1881 was estimated
by determining the amount of 3H-R1881 retained by cells that were
incubated with a 100-fold excess of R1881 (25).
Co-immunoprecipitation of the Androgen Receptor with Ydj1 and
Hsp70—AR was expressed under the control of the GAL promoter from
pG1-hAR (25) in ydj1 that harbored the indicated form pRS315YDJ1.
Cells were harvested and lysed by agitation with glass beads in 200 l
of lysis buffer composed of 50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA,
0.2% Triton X-100, 1 mM phenylmethylsulfonyl fluoride, and 1 prote-
ase inhibitor mixture. Insoluble material and unbroken cells were re-
moved from cell lysates by centrifugation at 10,000 rpm at 4 °C for 5
min. AR was immunoprecipitated from cleared cell extracts with -AR
(2 l; BD Biosciences) and protein G-agarose beads by standard tech-
niques. Immunoprecipitated proteins were resolved from each other on
10% SDS-PAGE gels and then transferred to a nitrocellulose mem-
brane. Membranes were probed with rabbit polyclonal -Ydj1 at a
1:5000 dilution, -Hsp70 at a 1:5000 dilution, or -AR at a 1:3000
dilution and developed with the ECL reagent (Amersham Biosciences).
Functional Assays with Purified Ydj1 ZFLR Mutants—Hsp70
(Hsp70 Ssa1), Ydj1, and the Ydj1 ZFLR mutants were purified as
described previously (28). The ability of Hsp70 and Ydj1 to refold
chemically denatured luciferase was determined with a Turner TD
20/20 luminometer by standard techniques (6, 29). Suppression of ther-
mally induced protein aggregation by Hsp70 and Ydj1 was determined
according to the published protocols (6). Regulation of Hsp70 ATPase
activity by Ydj1 and the Ydj1 ZFLR mutants was compared via thin
layer chromatography on polyethyleneimine cellulose plates (27, 28).
Measurement of complex formation between Ydj1 and the Ydj1 ZFLR
mutants with denatured luciferase was determined by ELISA (30).
Measurement of Ydj1-dependent Binding of Denatured Luciferase by
Hsp70—The ability of Ydj1 and the Ydj1 ZFLR mutants to promote
complex formation between Hsp70 and non-native polypeptides was
determined by ELISA. Briefly, chemically denatured luciferase (0.4
g/50 l of phosphate-buffered saline, PBS) was immobilized in the
wells of a 96-well microtiter plate. Wells were washed three times with
PBS that was supplemented with 0.02% Triton X-100 and then blocked
with PBS that contained 0.5% bovine serum albumin for 1 h at room
temperature. A mixture of Hsp70 (50 nM) and the indicated amount of
Ydj1 or Ydj1 ZFLR mutant (12.5–100 nM) in 50 l of PBS was then
added to the wells. Reaction cocktails were incubated at 25 °C for 1 h.
Hsp70 that did not bind to immobilized luciferase was removed by
washing the wells four times with PBS supplemented with 0.02% Triton
X-100. The quantity of Hsp70 that bound to immobilized luciferase was
detected by ELISA with rabbit polyclonal -Hsp70 Ssa1 serum (1:5000)
and goat -rabbit serum coupled with horseradish peroxidase. Color
formation was measured with a Bio-Rad Model 550 microplate reader
at 405 nM.
RESULTS
Analysis of Growth Defects Exhibited by Ydj1 ZFLR Mu-
tants—To investigate the biological importance of the Ydj1
ZFLR, we characterized functional defects exhibited by a set of
Ydj1 mutants that have point mutations in cysteine residues
located in ZBDI (C143S and C201S) and ZBDII (C162S and
C185S) (Fig. 1, A and B). First, we demonstrated that these
Ydj1 ZFLR point mutants were not prone to aggregation and
could accumulate to steady-state levels that were similar to
Ydj1 (Fig. 1C).
Next, we examined the importance of ZBDI and ZBDII in cell
physiology by determining the ability of Ydj1 ZBDI and ZBDII
mutants to support growth of ydj1 (Fig. 2A). Ydj1 is not
essential for growth, but ydj1 exhibits a slow growth pheno-
type at the permissive temperature and is inviable at 37 °C
(31). When cells were serially diluted and spotted onto selective
plates, ZBDII mutants Ydj1 C162S and Ydj1 C185S only sup-
ported slow growth at 25 °C and were inviable at 37 °C. In
contrast, ZBDI mutants Ydj1 C143S and Ydj1 C201S grew
normally at 25 °C and remained viable at 37 °C.
The overexpression of Sis1 can complement growth defects in
ydj1 (31). Hence, Sis1 that is present in the cytosol of ydj1 may
suppress some of the functional defects caused by mutation of
ZBDI or ZBDII. Therefore, we examined whether or not the
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function of the Ydj1 ZFLR becomes essential for cell viability
when Sis1 is absent from the cytosol. This was accomplished by
determination of the complementing activity of Ydj1 ZBDI and
ZBDII mutants in ydj1sis1 (Fig. 2B). Sis1 is an essential gene,
but ydj1sis1 can grow normally if Sis1 (1–121), which contains
the J domain and glycine and phenylalanine region but lacks its
polypeptide-binding domain, is co-expressed with fully functional
Ydj1 (21). ydj1sis1 was not viable when the plasmid shuffle
technique was utilized to exchange Ydj1 ZBDII mutants for Ydj1,
but Ydj1 ZBDI mutants could maintain the viability of this
strain. Thus, ZBDII in Ydj1 is required for cells to survive heat
stress and becomes essential for viability when yeast are forced to
depend upon Ydj1 chaperone function for growth.
The Ydj1 ZFLR Is Required for Androgen Receptor Func-
tion—To further explore the cellular functions of the Type I
Hsp40 ZFLR we examined the ability of the ZBDI mutant Ydj1
C143S and ZBDII mutant Ydj1 C162S to cooperate with Hsp70
to fold a heterologously expressed form of the hAR (25, 32, 33).
Mutation of ZBDI or ZBDII did not influence the steady-state
expression level of AR (Fig. 3A), yet when AR was co-expressed
with Ydj1 C143S or Ydj1 C162S its ligand binding activity was
reduced to a level near that observed in ydj1. Thus, even
though ZBDI and ZBDII appeared to have markedly different
importance in cell stress protection, both are required for
proper folding of AR.
To explore the mechanism behind the inability of Ydj1 ZBDI
and ZBDII mutants to support normal AR function we ana-
lyzed Ydj1AR and Hsp70AR complex formation in yeast that
were cultured at 25 °C (Fig. 4). AR was present at similar levels
in immunoprecipitates and Western blots prepared from cell
extracts from all strains (Fig. 4, A and B). However, in ydj1
and in strains that harbored Ydj1 C143S and Ydj1 C162S we
observed dramatic reductions in the levels of co-immunopre-
cipitable complexes formed between AR and Hsp70 (Fig. 4A). In
ydj1, we observed a 90% decrease in the level of Hsp70AR
complex formation. Likewise, Ydj1 C143S and Ydj1 C162S
supported 60–85% less Hsp70AR complex formation. Interest-
ingly, decreased Hsp70 binding to AR was accompanied by a
FIG. 1. Schematic of the Ydj1 ZFLR structure and expression
of levels of Ydj1 ZFLR mutants. A, a ribbon diagram of the x-ray
crystal structure of Ydj1 (110–337). Pro-110 and Glu-337 denote the
amino and carboxyl termini of the Ydj1 (110–337). The side chains for
Cys-201 and Cys-143 in zinc-binding domain (ZBD) I and Cys-162 and
Cys-185 in ZBDII are depicted while forming contacts with orange
spheres that represent zinc molecules. The red -strand bound to CTDI
corresponds to the peptide GWLYEIS that was co-crystallized with Ydj1
(110–337) (15). B, a ribbon diagram of Ydj1 (110–337) colored to show
the B-factors of amino acids in the x-ray crystal structure. The color
scale is from blue to red, where red corresponds to the highest B-factor
and blue the lowest. The range of B-factors reported for Ydj1 (110–337)
is 20–135, with a B-factor in the high range suggesting a large degree
of mobility for amino acids in the corresponding region of Ydj1. The
graphics displayed in panels A and B were produced with PYMol from
PBD 1NLT. C, Western blot analysis of Ydj1 ZFLR mutant expression
levels in ydj1. Ydj1 levels in the indicated cell extracts were estimated
by Western blot with rabbit -Ydj1. Levels of the marker protein phos-
phoglycerate kinase (PGK) were utilized as load control and were de-
tected with a mouse -PGK monoclonal antibody. The levels of Sis1 and
Hsp70 were also determined by Western blot with rabbit serum that
recognizes these respective proteins.
FIG. 2. Analysis of growth defects exhibited by Ydj1 ZFLR
mutants. A, comparison of the ability of Ydj1 ZFLR mutants to com-
plement growth defects exhibited by ydj1. Ydj1 and Ydj1 ZFLR mu-
tants in pRS315 were introduced into ydj1 by selection on synthetic
dextrose plates. Serial dilutions (1:10) of cultures were spotted on yeast
extract, peptone, and dextrose plates, incubated for 3 days at 25 and
37 °C, respectively, and then photographed. B, complementation of
ydj1sis1 by Ydj1ZFLR mutants. The genes of Ydj1 and Ydj1 ZFLR
mutants harbored in pRS412 were transformed into the ydj1sis1
strain JJ1146 that harbored pYCp50-Sis1 and pRS314-Sis1 (1–121).
Strains were selected on synthetic dextrose plates supplemented with
5-FOA to drive the loss of pYCp50-Sis1. Plates were incubated for 7
days at 25 °C and then photographed.
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1.5–2.5-fold increase in the level of Ydj1 ZFLR mutantAR
complex formation. The largest increase in Ydj1AR complex
formation was 2.5-fold and occurred with the ZBDI mutant
Ydj1 C143S, which supported 20% of the normal amount of
Hsp70AR complex formation and did not support AR function
above the level observed in ydj1 (Figs. 3 and 4). The ZBDII
mutant Ydj1 C162S supported AR function at 30% of wild type
levels, bound 1.5 times more AR, and supported Hsp70AR
complex formation at 40% of wild type Ydj1. Thus, the extent
to which AR accumulates in complexes with Ydj1 ZFLR mu-
tants correlates with reductions in Hsp70AR complex levels
and loss of AR activity.
A number of observations made from the data presented in
Fig. 4 suggested that reductions in AR activity and complex
formation with Hsp70 result from a specific defect in Ydj1
function and are not because of the nonspecific titration of
Hsp70 away from AR due to cell stress. First, strains that
harbored the Ydj1 ZBDI mutant C143S exhibited the largest
reduction in Hsp70AR complex formation and greatest loss of
AR function. However, Ydj1 C143S strains grew normally at
25 °C and did not appear to be stressed, because the expression
levels of stress-inducible proteins such as Sis1 and Hsp70 were
not elevated (Fig. 4B). Second, defects in AR function observed
in ydj1 were similar in severity to those exhibited by Ydj1
ZFLR mutants. Finally, decreased levels of Hsp70AR complex
formation were proportional to increases in the levels of Ydj1
ZBD mutantAR complexes. Hence, the data presented in Fig. 4
identify an AR biogenic intermediate whose folding has been
arrested by mutation of the ZFLR because it remains associ-
ated with Ydj1.
Purified Ydj1 ZBDI and ZBDII Mutants Fail to Promote
Polypeptide Binding by Hsp70 and Therefore Exhibit Defects in
Protein Folding—If Ydj1 ZBDI mutants can bind protein bio-
genic intermediates in vivo, then why cannot they promote
their proper folding? To address this question, the ability of
purified Ydj1 ZBDI and ZBDII mutants to interact with Hsp70
and facilitate the folding of chemically denatured luciferase
was examined. Luciferase was chosen as the substrate for these
studies instead of AR, because AR is a large metastable protein
that is not amenable to purification by standard techniques
and is not typically utilized in in vitro studies. Upon dilution
from denaturant, chemically denatured luciferase resembles a
nascent polypeptide that requires the action of Ydj1 and Hsp70
to reach the native state and is a widely utilized substrate for
mechanistic studies on chaperone-assisted protein folding (2, 3).
In protein folding assays, purified Ydj1 C143S and Ydj1
C162S behaved like the J domain mutant, Ydj1 H34Q, and
were incapable of cooperating with Hsp70 to reactivate chem-
ically denatured luciferase (Fig. 5A). These luciferase refolding
reactions were carried out at an optimal Ydj1:Hsp70 molar
ratio of 2:1, and when the Ydj1 ZFLR mutant:Hsp70 molar
ratio was increased from 2:1 to 10:1 no increase in luciferase
refolding was observed (data not shown). Thus, defects in the
ability of Ydj1 ZDB1 and ZBDII mutants to support AR folding
in vivo correlate well with the inability of purified Ydj1 C143S
and Ydj1 C162S to interact with Hsp70 to refold chemically
denatured luciferase.
FIG. 3. Assay for androgen receptor (AR) function in ydj1 that
harbors Ydj1 ZFLR mutants. A, Western blot analysis of AR expres-
sion in strains that harbor the indicated Ydj1 ZFLR mutant. B, binding
of androgen by AR. The synthetic androgen 3H-R1881 (50 nM) was
added to liquid cultures of strains that harbored Ydj1 or the indicated
Ydj1 ZFLR mutant. Binding of 3H-R1881 to AR was assayed at the
permissive growth temperature and quantitated as described under
“Experimental Procedures.” Results displayed represent the average
from three experiments  S.D.
FIG. 4. Analysis of complex formation between AR and Hsp70
and Ydj1. A, Ydj1 that harbored the indicated form of Ydj1 and
pG1-hAR, which expresses AR under control of the GAL promoter, were
cultured in synthetic media that was supplemented with 2% raffinose
at 25 °C to an A600 nm of 0.2. AR expression was then induced by
addition of 2% galactose, and cells were grown to an A600 nm of 1.6 and
then harvested. Cells were lysed by agitation with glass beads, and AR
was immunoprecipitated from cleared cell extracts with -AR. The
amounts of Ydj1 and Hsp70 that co-precipitated with AR were detected
by Western blot with -Ydj1 and -Hsp70, respectively (top panel). B,
Western blot analysis of Hsp70, Ydj1, AR, and phosphoglycerate kinase
(PGK) levels in the total cell extracts that were utilized for the co-
immunoprecipitation experiments shown in panel A.
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To uncover the mechanism for the protein-folding defect
exhibited by Ydj1 ZFLR mutants, the ability of Ydj1 C143S and
Ydj1 C162S to regulate the ATPase activity of Hsp70 was
examined. This is an important question because, to promote
substrate binding by Hsp70 and thereby facilitate protein fold-
ing, Ydj1 must interact with Hsp70 to stimulate its ATPase
activity (34). Ydj1 C143S and Ydj1 C162S were fully active in
the stimulation of Hsp70 ATPase activity (Fig. 5B). Hence, the
protein folding defects exhibited by these ZFLR mutants can-
not be attributed to a defect in their ability to regulate Hsp70
ATPase activity.
To facilitate Hsp70-dependent refolding of denatured lucif-
FIG. 5. Functional analysis of purified Ydj1 ZFLR mutants. A, refolding of denatured luciferase by Ydj1 and Hsp70. Guanidine-HCL-
denatured luciferase (50 nM) was incubated at 30 °C for 60 min with Hsp70 (0.5 M) and the indicated form of Ydj1 (1 M) in refolding buffer (25
mM Hepes, pH 7.4, 50 mM KCl, 5 mM MgCl2, 1 mM ATP). Aliquots of reaction mixtures were removed and assayed for luciferase activity with a
Turner TD-20/20 luminometer. Luciferase refolding activity is expressed as a percentage of the total luciferase activity observed when refolding
reactions contained Hsp70 and Ydj1. The results displayed represent the average of three trials  S.D. B, stimulation of Hsp70 ATPase activity
by Ydj1 ZFLR mutants. Purified Hsp70 (0.5 M) and the indicated forms of Ydj1 (1 M) were incubated with [-32P]ATP (50 M) at 30 °C for 10
min. ADP formation was measured by thin layer chromatography on polyethyleneimine-cellulose plates and quantified by scintillation counting.
The top panel represents a photograph of x-ray film that was exposed to the polyethyleneimine plate on which the reaction mixtures from a
representative experiment were spotted. Values shown are means of two assays. C, measurement of complex formation between Ydj1 ZFLR
mutants and denatured luciferase. The indicated form of Ydj1 was immobilized in the well of a 96-well microtiter plate. Chemically denatured
luciferase (0.4 g) was added to each well. Wells were washed with PBS supplemented with 0.02% Triton X-100; ELISA determined the quantity
of luciferase retained with -luciferase. The quantity of luciferase bound to Ydj1 was set as 100% of control, and the values presented are expressed
as a percentage of this value. Values shown represent the average of three assays  S.D. D, Ydj1-dependent promotion of luciferase binding by
Hsp70. Chemically denatured luciferase (0.4 g) was immobilized in the wells of a 96-well microtiter plate. Wells were washed three times with
PBS that contained 0.02% Triton X-100 and blocked with 0.5% bovine serum albumin. Hsp70 (50 nM) and different amounts of the indicated form
of Ydj1 (12.5–100 nM) were mixed in PBS in the presence or absence of 1 mM ATP. The quantity of Hsp70 that bound to immobilized luciferase and
was retained in the wells was detected with -Hsp70. Values are expressed as a percentage of luciferase bound to Hsp70 in the presence of Ydj1
and 1 mM ATP. Results are the means of two independent assays.
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erase, Ydj1 must bind and then deliver non-native luciferase to
the Hsp70 polypeptide-binding domain (29). Hence, to deter-
mine whether Ydj1 ZFLR mutants exhibit a defect in this
aspect of Ydj1 function we examined the ability of Ydj1 C143S
and Ydj1 C162S to bind chemically denatured luciferase (Fig.
5C). Ydj1 C143S and Ydj1 C162S retained their polypeptide
binding function and bound a quantity of chemically denatured
luciferase that was similar to the quantity that associated with
Ydj1. Thus, mutation of ZBDI or ZBDII does not alter the
ability of Ydj1 to bind chemically denatured luciferase.
Because Ydj1 ZBDI and ZBDII mutants function to bind
luciferase and form complexes with AR (Fig. 4), it appears that
the protein folding defect caused by mutation of the ZFLR
manifests itself after polypeptide binding by Ydj1. Therefore,
function of the ZFLR might be required for the efficient trans-
fer of polypeptides from Ydj1 to Hsp70. If this is the case, Ydj1
ZFLR mutants should exhibit a defect in stimulating polypep-
tide binding by Hsp70. To investigate this possibility, we de-
veloped an ELISA assay to monitor the Ydj1-dependent bind-
ing of luciferase by Hsp70 (Fig. 5D). Chemically denatured
luciferase was immobilized in the wells of a microtiter plate,
and purified Hsp70 was added alone or in combination with
Ydj1. The quantity of Hsp70 that bound to the immobilized
luciferase was then quantitated via ELISA with -Hsp70. In
the absence of Ydj1, Hsp70 bound a small quantity of lucifer-
ase. However, when Ydj1 was included in reactions, 5-fold more
Hsp70luciferase complex formation occurred. The Ydj1-
dependent increase in the binding of Hsp70 to luciferase was
deemed to be specific because it was ATP-dependent and not
supported by Ydj1 H34Q. When Ydj1 C143S or Ydj1 C162S was
substituted in reactions for Ydj1, it was incapable of stimulat-
ing substrate binding by Hsp70. Thus, function of the ZFLR is
required for Ydj1 to promote complex formation between Hsp70
and chemically denatured luciferase.
The inability of Ydj1 ZFLR mutants to promote luciferase
binding by Hsp70 appears to be the cause of their inability to
cooperate with Hsp70 to refold denatured luciferase. In addi-
tion, these data help explain the mechanism behind the in vivo
observation that, instead of being bound by Hsp70, AR biogenic
intermediates accumulate in complexes with Ydj1 ZFLR mu-
tants. Thus, data from in vivo and in vitro studies suggest that
the Type I Hsp40 ZFLR plays an important role in chaperone-
assisted protein folding by promoting substrate transfer from
Ydj1 to Hsp70.
Mutation of ZBDII, but Not ZBDI, Interferes with the Ability
of Ydj1 to Cooperate with Hsp70 to Suppress Thermally In-
duced Protein Aggregation—If mutation of ZBDI and ZBDII
hinders the ability of Ydj1 to cooperate with Hsp70 to fold
nascent AR and refold chemically denatured luciferase, then
why do yeast that harbor Ydj1 ZBDI mutants survive heat
stress but Ydj1 ZBDII mutants become inviable (Fig. 2)? Be-
cause protein synthesis is inhibited during heat stress, the
major cytoprotective function of the Hsp70/Hsp40 system at
elevated temperatures is to suppress the aggregation of native
proteins that become unfolded (1–3). Therefore, we explored
whether the differences in the sensitivity of strains that har-
bored Ydj1 ZBDI and Ydj1 ZBDII mutants to thermal stress
reflected differences in the ability of these proteins to cooperate
with Hsp70 to suppress heat-induced protein aggregation.
To accomplish this, the ability of Ydj1, Ydj1 C143S, and Ydj1
C162S to act alone and in combination with Hsp70 to suppress
the thermally induced aggregation of native firefly luciferase was
compared (Fig. 6). Upon incubation of native luciferase at 42 °C
for 10 min, 90% of it formed large aggregates that could be
pelleted from reaction cocktails by centrifugation (Fig. 6B, col-
umn 1). When Ydj1 or Hsp70 was added individually to reaction
cocktails during the heat treatment, luciferase aggregation was
suppressed by only 5–10% (Fig. 6B, column 1 versus columns 2
and 6). The combination of Ydj1 and Hsp70 maintained 90% of
total luciferase in a soluble state (Fig. 6B, column 1 versus 7). The
ability of Ydj1 and Hsp70 to jointly suppress luciferase aggrega-
tion required them to functionally interact because Ydj1 H34Q
could not substitute for Ydj1 (Fig. 6B, column 1 versus columns 7
and 10). Surprisingly, Ydj1 C143S could function in combination
with Hsp70 to suppress luciferase aggregation to the same de-
gree as Ydj1 (Fig. 6B, column 1 versus columns 7 and 8). In
contrast, Ydj1 C162S was incapable of cooperating with Hsp70 to
prevent luciferase aggregation.
Thus, Ydj1 C162S appears incapable of supporting the
growth of yeast at the non-permissive temperature, because
loss of ZBDII function prevents it from cooperating with Hsp70
to suppress heat stress-induced protein denaturation. In con-
trast, the ZBDI mutant Ydj1 C143S is partially functional
because it retains its ability to cooperate with Hsp70 to sup-
press protein aggregation and can thereby protect cells from
heat stress.
DISCUSSION
The experimental data presented indicate that proper func-
tion of the Type I Hsp40 ZFLR is required for Hsp70 to capture
non-native proteins from Ydj1. This function of the Ydj1 ZFLR
appears to be important for cell physiology because mutation of
ZBDII caused ydj1sis1 to become inviable and prevented
ydj1 from surviving heat stress. The following observations
support the conclusion that the ZFLR facilitates substrate
transfer from Ydj1 to Hsp70. First, mutation of theYdj1 ZFLR
caused defects in AR function that were associated with a
dramatic decrease in Hsp70AR complex formation and the
accumulation of Ydj1AR complexes. Second, purified Ydj1
ZFLR mutants were defective at cooperating with Hsp70 to
refold chemically denatured luciferase but retained the ability
to bind denatured luciferase and stimulate Hsp70 ATPase ac-
tivity. Finally, Ydj1 ZFLR mutants were incapable of promot-
ing Hsp70luciferase complex formation.
During the course of these studies we compared the influence
that mutation of ZBDI and ZBDII had on Ydj1 function and
observed some similarities and differences. Mutation of ZDBI
and ZBDII blocked the in vivo and in vitro protein folding activity
of Ydj1, and this defect correlated with the inability of ZFLR
mutants to promote substrate binding by Hsp70. However, Ydj1
ZBDI mutants were able to support the normal growth of ydj1
and ydj1sis1 and could also protect cells from heat stress,
whereas Ydj1 ZBDII mutants could not support the growth of
ydj1sis1 and could not protect ydj1 from heat stress. There-
fore, the functional defects exhibited by Ydj1 ZBDII mutants
were more severe, and Ydj1 ZBDI mutants were partially func-
tional. A function that was retained by Ydj1 ZBDI mutants, but
was lost by ZBDII mutants, was the ability to cooperate with
Hsp70 to suppress thermally induced protein aggregation. Re-
tention of the ability to cooperate with Hsp70 to suppress ther-
mally induced protein aggregation helps to explain why ZBDI
mutants can protect cells from heat stress. An explanation as to
why ZBDI mutants were only partially defective in the execution
of Ydj1 chaperone function is presented below.
Ydj1 appears to function as a dimer. When the crystal struc-
ture of monomeric Ydj1 (110–337) is modeled as dimer it is
predicted to form a U-shaped assembly in which the rod-like
ZFLRs on adjacent monomers protrude toward each other (15).
The distance that separates the ZFLRs on each monomer in the
Ydj1 dimer appears short enough to allow for interactions
between the -strands located at the tips of each ZFLR to occur.
The formation of intermolecular contacts between adjacent
ZFLRs in the Ydj1 dimer may be functionally important be-
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cause it would fix the distance between the polypeptide binding
pockets found on CTDI. This putative event could be required
for Ydj1 to maintain polypeptides in a conformation that can be
bound by Hsp70.
Portions of the Ydj1 ZFLR appear to be flexible because the
B-factors for amino acid residues that surround ZBDI and
ZBDII are as high as 130 (Fig. 1B). Therefore, mutation of
either ZBDI or ZBDII could cause defects in Ydj1 function by
destabilizing local secondary structure. ZBDI is located at the
junction between CTDI and the ZFLR, so the introduction of a
single point mutation into ZBDI is predicted to increase the
flexibility of this junction but should not dramatically influence
the overall ZFLR structure. ZBDII, on the other hand, is lo-
cated in the middle of the ZFLR and is surrounded by amino
acids that have relatively high B-factors (Fig. 1B). Hence, the
mutation of ZBDII has the potential to disrupt the rod-like
shape of the ZFLR and render it non-functional. If this scenario
were proven to be true, then it would explain why mutation of
ZBDII is more detrimental to Ydj1 function than mutation
of ZBDI.
The ZFLRs from Ydj1 and DnaJ are structurally conserved,
and the data we have presented suggest that they also perform
related functions (15–18). Zylicz and co-workers (17) have in-
vestigated the functional importance of the DnaJ ZFLR by
FIG. 6. Ydj1 ZBDI and ZBDII exhibit differential defects in their ability to cooperate with Hsp70 to suppress luciferase aggrega-
tion. A, suppression of luciferase aggregation by Hsp70 and Ydj1. Luciferase (100 nM) was mixed with Hsp70 (2 M) and the indicated form of Ydj1
(3 M) and incubated at 42 °C for 10 min. Reaction cocktails were then subjected to centrifugation at 20,000 rpm for 10 min at 4 °C. Total (T)
luciferase and luciferase that was present in the supernatant (S) and pellet (P) from equal portions of reaction mixtures were then determined by
Western blot with -luciferase. B, quantitation of luciferase present in the soluble fraction and pellets of reaction mixtures shown in panel A.
Western blots were quantitated by laser densitometry; values are presented as percentage of total luciferase present in individual reactions.
Soluble represents luciferase detected in the supernatant fraction after centrifugation. Aggregated material represents luciferase detected in the
pellet after centrifugation.
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characterizing defects exhibited by DnaJZFLR. DnaJZFLR
retained its ability to bind DnaJ substrates but exhibited a
reduced capacity to prime E. coli Hsp70 (DnaK) for substrate
binding (17). However, direct interactions between DnaK and
DnaJ were not impaired in DnaJZFLR (17). In a recent study,
site-directed mutagenesis was carried out on the DnaJ ZFLR in
which all four of the cysteines that form ZBDI or ZBDII were
mutated (18). Mutation of DnaJ ZBDI impaired the autono-
mous polypeptide binding activity of DnaJ but had little influ-
ence on the growth of E. coli (18). These results differ from data
obtained with Ydj1 ZBDI point mutants, because mutation of
Ydj1 C143S or Ydj1 C201S had no effect on the polypeptide
binding activity of Ydj1. Data obtained with Ydj1 ZBDI and
DnaJ ZBDI mutants may differ because mutation of all four
residues in DnaJ ZBDI may lead to destabilization of adjacent
regions in CTDI that are involved in polypeptide binding (15,
18), whereas the introduction of single point mutations in Ydj1
ZBDI might only influence ZFLR function.
Characterization of DnaJ ZBDII mutants yielded similar
results to those exhibited by Ydj1 ZBDII mutants. DnaJ ZBDII
mutants grew slowly at 37 °C and were inviable at 43 °C (18).
Purified DnaJ ZBDII mutants were unable to cooperate with
DnaK to suppress protein aggregation (18). Thus, results we
have reported from studies on the function of the Ydj1 ZFLR
are in good agreement with functional features of the DnaJ
ZFLR. However, the data reported here extend previous of
knowledge of Type I Hsp40 ZFLR action because we demon-
strated for the first time that loss of ZFLR function leads to the
accumulation of complexes between Ydj1 and protein folding
intermediates and limits the ability of Hsp70 to form complexes
with substrates of Ydj1. Thus, it appears that the Type I Hsp40
ZFLR and the J domain act synergistically to enable Hsp70 to
capture non-native polypeptides from Ydj1.
Acknowledgments—We thank Elizabeth Craig for providing strains
and plasmids and Brenda Temple at the Structural Bioinformatics Core
Facility at UNC-Chapel Hill for assistance with graphics. We thank
Meg Scully and Meredith F. N. Rosser for critical reading of the
manuscript.
REFERENCES
1. Cyr, D. M., Langer, T., and Douglas, M. G. (1994) Trends Biochem. Sci. 19,
176–181
2. Cheetham, M. E., and Caplan, A. J. (1998) Cell Stress Chaperones 3, 28–36
3. Hartl, F. U., and Hayer-Hartl, M. (2002) Science 295, 1852–1858
4. Luke, M. M., Sutton, A., and Arndt, K. T. (1991) J. Cell Biol. 114, 623–638
5. Caplan, A. J., and Douglas, M. G. (1991) J. Cell Biol. 114, 609–621
6. Lu, Z., and Cyr, D. M. (1998) J. Biol. Chem. 273, 27824–27830
7. Lopez, N., Aron, R., and Craig, E. A. (2003) Mol. Biol. Cell 14, 1172–1181
8. Fan, C. Y., Lee, S., Ren, H. Y., and Cyr, D. M. (2004) Mol. Biol. Cell 15,
761–773
9. Wickner, S., Hoskins, J., and McKenney, K. (1991) Nature 350, 165–167
10. Langer, T., Lu, C., Echols, H., Flanagan, J., Hayer, M. K., and Hartl, F. U.
(1992) Nature 356, 683–689
11. Cyr, D. M. (1995) FEBS Lett. 359, 129–132
12. Rudiger, S., Germeroth, L., Schneider-Mergener, J., and Bukau, B. (1997)
EMBO J. 16, 1501–1507
13. Han, W., and Christen, P. (2003) J. Biol. Chem. 278, 19038–19043
14. Wall, D., Zylicz, M., and Georgopoulos, C. (1994) J. Biol. Chem. 269,
5446–5451
15. Li, J., Qian, X., and Sha, B. (2003) Structure 11, 1475–1483
16. Martinez-Yamout, M., Legge, G. B., Zhang, O., Wright, P. E., and Dyson, H. J.
(2000) J. Mol. Biol. 300, 805–818
17. Banecki, B., Liberek, K., Wall, D., Wawrzynow, A., Georgopoulos, C., Bertoli,
E., Tanfani, F., and Zylicz, M. (1996) J. Biol. Chem. 271, 14840–14848
18. Linke, K., Wolfram, T., Bussemer, J., and Jakob, U. (2003) J. Biol. Chem. 278,
44457–44466
19. Szabo, A., Korszun, R., Hartl, F. U., and Flanagan, J. (1996) EMBO J. 15,
408–417
20. Atencio, D. P., and Yaffe, M. P. (1992) Mol. Cell. Biol. 12, 283–291
21. Johnson, J. L., and Craig, E. A. (2001) J. Cell Biol. 152, 851–856
22. Sikorski, R. S., and Hieter, P. (1989) Genetics 122, 19–27
23. Studier, F. W., Rosenberg, A. H., Dunn, J. J., and Dubendorff, J. W. (1990)
Methods Enzymol. 185, 60–89
24. Yaglom, J. A., Goldberg, A. L., Finley, D., and Sherman, M. Y. (1996) Mol. Cell.
Biol. 16, 3679–3684
25. Caplan, A. J., Langley, E., Wilson, E. M., and Vidal, J. (1995) J. Biol. Chem.
270, 5251–5257
26. Boeke, J. D., Trueheart, J., Natsoulis, G., and Fink, G. R. (1987) Methods
Enzymol. 154, 164–175
27. Meacham, G. C., Lu, Z., King, S., Sorscher, E., Tousson, A., and Cyr, D. M.
(1999) EMBO J. 18, 1492–1505
28. Cyr, D. M., Lu, X., and Douglas, M. G. (1992) J. Biol. Chem. 267, 20927–20931
29. Lu, Z., and Cyr, D. M. (1998) J. Biol. Chem. 273, 5970–5978
30. Lee, S., Fan, C. Y., Younger, J. M., Ren, H., and Cyr, D. M. (2002) J. Biol.
Chem. 277, 21675–21682
31. Caplan, A. J., Cyr, D. M., and Douglas, M. G. (1992) Cell 71, 1143–1155
32. Caplan, A. J. (1999) Trends Cell Biol. 9, 262–268
33. Fliss, A. E., Rao, J., Melville, M. W., Cheetham, M. E., and Caplan, A. J. (1999)
J. Biol. Chem. 274, 34045–34052
34. Tsai, J., and Douglas, M. G. (1996) J. Biol. Chem. 271, 9347–9354
Regulation of Hsp70 by Hsp40702
